Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Since 2005, a large poliomyelitis outbreak associated with type 2 circulating vaccine-derived poliovirus (cVDPV2) has occurred in northern Nigeria, where immunization coverage with trivalent oral poliovirus vaccine (tOPV) has been low. Phylogenetic analysis of P1/capsid region sequences of isolates from each of the 403 cases reported in 2005 to 2011 resolved the outbreak into 23 independent type 2 vaccine-derived poliovirus (VDPV2) emergences, at least 7 of which established circulating lineage groups. Virus from one emergence (lineage group 2005-8; 361 isolates) was estimated to have circulated for over 6 years. The population of the major cVDPV2 lineage group expanded rapidly in early 2009, fell sharply after two tOPV rounds in mid-2009, and gradually expanded again through 2011. The two major determinants of attenuation of the Sabin 2 oral poliovirus vaccine strain (A 481 in the 5′-untranslated region [5′-UTR] and VP1-Ile 143 ) had been replaced in all VDPV2 isolates; most A 481 5′-UTR replacements occurred by recombination with other enteroviruses. cVDPV2 isolates representing different lineage groups had biological properties indistinguishable from those of wild polioviruses, including efficient growth in neuron-derived HEK293 cells, the capacity to cause paralytic disease in both humans and PVR-Tg21 transgenic mice, loss of the temperature-sensitive phenotype, and the capacity for sustained person-to-person transmission. We estimate from the poliomyelitis case count and the paralytic case-to-infection ratio for type 2 wild poliovirus infections that ∼700,000 cVDPV2 infections have occurred during the outbreak. The detection of multiple concurrent cVDPV2 outbreaks in northern Nigeria highlights the risks of cVDPV emergence accompanying tOPV use at low rates of coverage in developing countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“after the disease has been eliminated in developing countries, low polio vaccine coverage frequently enables the emergence of VDPVs or the reintroduction of wild-type PV from disease-endemic countries”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombination of an OPV strain with co-circulating enterovirus C species allowed the Sabin2 domV to be replaced by that of a WT co-circulating enterovirus to provide a thermostable structure, thereby restoring viral fitness (Burns et al., 2013, Stern et al., 2017).”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Burns et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Among the different categories of VDPVs, cVDPVs are currently the greatest public health concern [87,88].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [87]
In the citing paper
“both scenarios threaten the success of the poliomyelitis eradication program (9,10).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [10]
In the citing paper
“Les cPVDV originaires du Cameroun, du Tchad et du Nigéria, qui ont été caractérisés, se sont avérés être des recombinants entre des souches du VPO et d'autres HEV-C non vaccinaux [26].”
From Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun (2013) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 39,969
MrBayes 3: Bayesian phylogenetic inference under mixed models
Ronquist, F., & Huelsenbeck, J. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg180 · Cited by 29,077
MODELTEST: testing the model of DNA substitution.
Posada, D., & Crandall, K. A. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.817 · Cited by 19,820
Bayesian Phylogenetics with BEAUti and the BEAST 1.7
Drummond, A. J., Suchard, M. A., Xie, D., & Rambaut, A. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss075 · Cited by 10,063
Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences
Drummond, A. J. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi103 · Cited by 3,143
Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche
Kärber, G. (1931) · Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01863914 · Cited by 3,104
On the genealogy of large populations
Kingmán, J. F. C. (1982) · Journal of Applied Probability · doi:10.1017/s0021900200034446 · Cited by 1,628
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,260
Shaw, G., Morse, S., Ararat, M., & Graham, F. L. (2002) · The FASEB Journal · doi:10.1096/fj.01-0995fje · Cited by 797
Ayres, D. L., Darling, A., Zwickl, D. J., Beerli, P., Holder, M. T., Lewis, P. O., Huelsenbeck, J. P., Ronquist, F., Swofford, D. L., Cummings, M. P., et al. (2012) · Systematic Biology · doi:10.1093/sysbio/syr100 · Cited by 706
Research works printed but not linked: 5
- 10.1001/jama.1987.03390100073029 · doi:10.1001/jama.1987.03390100073029 · Paper page
- World Health Organization. 2004. Polio laboratory manual, 4th ed. World Health Organization, Geneva, Switzerland.
- 10.2307/3213548 · doi:10.2307/3213548 · Paper page
- SabinAB. 1959. Recent studies and field tests with a live attenuated poliovirus vaccine, p 14–33. In Live poliovirus vaccines: papers presented and discussions held at the First International Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau, Washington, DC.
- FoxJP LeBlancDR GelfandHM ClemmerDJ PotashL. 1960. Spread of a vaccine strain of poliovirus in southern Louisiana communities, p 144–155. In Second International Conference on Live Poliovirus Vaccines. Pan American Health Organization scientific publication no 60. Pan American Health Organization, Washington, DC.
Cited by
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
Self-citationEngineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Update on Vaccine-Derived Polioviruses-Worldwide, January 2017–June 2018
Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Sutter, R. W., Wassilak, S. G. F., & Burns, C. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6742a5 · Cited by 197
Self-citationPlant‐made oral vaccines against human infectious diseases—Are we there yet?
Chan, H., & Daniell, H. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12471 · Cited by 149
Enteroviruses in the early 21st century: new manifestations and challenges
Lugo, D. J., & Krogstad, P. A. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000303 · Cited by 149
Metadata
- Authors
- Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., Chen, Q., Vincent, A., Chenoweth, P., Henderson, E., Wannemuehler, K., Naeem, A., Umami, R. N., Nishimura, Y., Shimizu, H., Baba, M., Adeniji, A., Williams, A. J., Kilpatrick, D. R., Oberste, M. S., Wassilak, S. G., Tomori, O., Pallansch, M. A., & Kew, O.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of Maiduguri (NG)
- University of Ibadan (NG)
- National Institute for Communicable Diseases (ZA)
- National Primary Health Care Development Agency (NG)
- World Health Organization - Nigeria (NG)
- National Institute of Infectious Diseases (JP)
- University of Maiduguri Teaching Hospital, Maiduguri,
- Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria
- Redeemer's University (NG)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2013-05
- Volume
- 87
- Issue
- 9
- Pages
- 4907-4922
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3624331
- OpenAlex
- W2031551277
- Semantic Scholar
- 3a3e1de660dee4591ab452c7f0489e8faf9b43a8
- Cited by
- 153
- References
- 102
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 12 · 2021: 5 · 2020: 17 · 2019: 9 · 2018: 11 · 2017: 12 · 2016: 21 · 2015: 17 · 2014: 19 · 2013: 9
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- World Health Organization
- Centers for Disease Control and Prevention
- Japan Society for the Promotion of Science (25293111, 22390092)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- poliomyelitis outbreak, trivalent oral polio vaccine, vaccine attenuation, human-to-human transmission, Northern Nigeria
- MeSH terms
- Animals, Disease Outbreaks, Female, Humans, Male, Molecular Sequence Data, Nigeria, Phylogeny, Poliomyelitis, Poliovirus Vaccine, Oral, Poliovirus, Poliovirus Vaccines, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria. https://app.cochat.ai/papers/10.1128/jvi.02954-12
- The paper
- Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., Chen, Q., Vincent, A., Chenoweth, P., Henderson, E., Wannemuehler, K., Naeem, A., Umami, R. N., Nishimura, Y., Shimizu, H., . . . Kew, O. (2013). Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria. Journal of Virology. https://doi.org/10.1128/jvi.02954-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.